1177 — Sino Biopharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$98.09bn
- HK$101.92bn
- CNY31.83bn
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit
Brief: Sino Biopharmaceutical Says SBP Group To Buy 5% Equity Interest In CT Tianqing For RMB4.48 Billion At 19X LTM P/E
Sino Biopharmaceutical climbs on FDA approval for cancer drug trial
Brief: Sino Biopharmaceutical Says FDA Grants IND Approval For TQB6426 'GPC3 ADC' For Advanced Malignant Tumors
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
Chinese vaccine makers jump on news of key success in cancer treatment
Chinese vaccine makers jump on news of key success in cancer treatment, CanSino leads
Brief: Sino Biopharmaceutical - Launches New Global Brand Sbp Group
Sino Biopharmaceutical H1 revenue up 10.6% on innovative drug sales
Brief: Sino Biopharmaceutical Says NMPA Approves Benmelstobart
Brief: Sino Biopharmaceutical Says Second-Generation Flurbiprofen Patch Approved For Marketing
Brief: Sino Biopharmaceutical Says New Drug Application For TQB3909 Tablet Accepted By China's CDE
Brief: Sino Biopharmaceutical Enters Joint Venture With Tempo Scan
Brief: Sino Biopharmaceutical Says Trd205 Granted Breakthrough Therapy Designation By China's
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQB3454 Tablet 'IDH1 Inhibitor'